Erythropoietin Terminated Phase 4 Trials for Anemias Treatment

IndicationsStatusPurposePhase
TerminatedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00440063A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia.
NCT00511901Prevalence and Treatment of Anemia in Rehabilitation Patients
NCT00211120Correction of Hemoglobin and Outcomes in Renal Insufficiency (CHOIR)
NCT01737879Evaluation of the Conversion From Peginesatide to Epoetin Alfa in Patients Receiving Hemodialysis
NCT02608060A Study to Assess the Hematopoyetic Response of Anemic Patients With Hematologic Malignancies Treated With Erythropoietin B
NCT02624141A Study of Recormon (Epoetin Beta) in Anemic Patients With Non-Myeloid Malignancy